@article{ref1,
title="Review: Should ethanol be scheduled as a drug of high risk to public health?",
journal="Journal of psychopharmacology",
year="2009",
author="Sellman, Jd and Robinson, Gm and Beasley, R.",
volume="23",
number="1",
pages="94-100",
abstract="Six criteria described in the New Zealand Misuse of Drugs Act and used by the Expert Advisory Committee on Drugs (EACD) for determining the risk of a drug to public health were examined in relation to ethanol, using γ-hydroxybutyric acid (GHB) as a comparator drug. GHB is an ideal candidate for use as a comparator because it is a sedative substance very similar to ethanol and has been previously investigated by the EACD using these six criteria. GHB was subsequently classified as a Class B1 drug under the Misuse of Drugs Act, that is, as a prohibited drug of high risk to public health. The dangerousness level of ethanol was found to be at least similar to that of GHB in this analysis. This highlights a major discrepancy in public policy.<p />",
language="",
issn="0269-8811",
doi="10.1177/0269881108091596",
url="http://dx.doi.org/10.1177/0269881108091596"
}